ENTRADA THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ENTRADA THERAPEUTICS, INC. (TRDA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$180.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$180.00K.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$406.00K, a 184.58% decline year-over-year.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $31.00K.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $221.00K, a 83.01% decline year-over-year.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $695.00K.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$238.00K, a 110.57% decline from fiscal 2023.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $2.25M.
- ENTRADA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$2.06M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$180.00K 10-Q · filed 2026-08-05 | -$586.00K 10-Q · filed 2026-08-05 | -$555.00K derived: sum of 3 quarters · filed 2026-08-05 | -$334.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$406.00K 10-Q · filed 2026-08-05 | -$375.00K derived: sum of 2 quarters · filed 2026-08-05 | -$154.00K derived: sum of 3 quarters · filed 2026-08-05 | -$191.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $252.00K derived: sum of 2 quarters · filed 2026-02-26 | $215.00K derived: sum of 3 quarters · filed 2026-08-05 | $695.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $221.00K 10-Q · filed 2025-11-06 | $184.00K derived: sum of 2 quarters · filed 2026-08-05 | $664.00K 10-Q · filed 2025-11-06 | -$351.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$37.00K 10-Q · filed 2026-08-05 | $443.00K 10-Q · filed 2026-08-05 | -$572.00K derived: sum of 3 quarters · filed 2026-08-05 | $729.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $480.00K 10-Q · filed 2026-08-05 | -$535.00K derived: sum of 2 quarters · filed 2026-08-05 | $766.00K derived: sum of 3 quarters · filed 2026-08-05 | $683.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2024-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $286.00K derived: sum of 2 quarters · filed 2026-02-26 | $203.00K derived: sum of 3 quarters · filed 2026-02-26 | -$238.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.30M 10-Q · filed 2025-11-06 | $1.22M derived: sum of 2 quarters · filed 2025-11-06 | $777.00K 10-Q · filed 2025-11-06 | $1.47M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$83.00K 10-Q · filed 2025-11-06 | -$524.00K 10-Q · filed 2025-08-06 | $167.00K derived: sum of 3 quarters · filed 2025-11-06 | $676.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-03-31 | -$441.00K 10-Q · filed 2025-11-06 | $250.00K derived: sum of 2 quarters · filed 2025-11-06 | $759.00K derived: sum of 3 quarters · filed 2025-11-06 | $396.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2023-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.20M derived: sum of 2 quarters · filed 2025-02-27 | $837.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.25M 10-K · filed 2025-02-27 |
| 2023-09-30 | $509.00K 10-Q · filed 2024-11-05 | $146.00K derived: sum of 2 quarters · filed 2024-11-05 | $1.56M 10-Q · filed 2024-11-05 | $2.25M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$363.00K 10-Q · filed 2024-11-05 | $1.05M 10-Q · filed 2024-08-13 | $1.74M derived: sum of 3 quarters · filed 2024-11-05 | $1.26M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-03-31 | $1.42M 10-Q · filed 2024-11-05 | $2.10M derived: sum of 2 quarters · filed 2024-11-05 | $1.62M derived: sum of 3 quarters · filed 2024-11-05 | $893.00K derived: sum of 4 quarters · filed 2024-11-05 |
| 2022-12-31 | $690.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $208.00K derived: sum of 2 quarters · filed 2024-03-13 | -$522.00K derived: sum of 3 quarters · filed 2024-03-13 | -$2.06M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$482.00K 10-Q · filed 2023-11-07 | -$1.21M derived: sum of 2 quarters · filed 2023-11-07 | -$2.75M 10-Q · filed 2023-11-07 | -$2.75M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$730.00K 10-Q · filed 2023-11-07 | -$2.27M 10-Q · filed 2023-08-08 | -$2.27M derived: sum of 3 quarters · filed 2023-11-07 | -$2.27M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-03-31 | -$1.53M 10-Q · filed 2023-11-07 | -$1.53M derived: sum of 2 quarters · filed 2023-11-07 | -$1.53M derived: sum of 3 quarters · filed 2023-11-07 | -$1.53M derived: sum of 4 quarters · filed 2023-11-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $0.00 10-K · filed 2023-03-06 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |